Advances in Immunology, Volume 147, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Chapters in this new release include Histone deacetylases as targets in autoimmune and autoinflammatory diseases, The advancing area of the mechanisms involved in the evolution of HIV-1 neutralizing antibodies, T cells in latent viral infections, Communications of dendritic cells with T cells and NK cells in cancerous tissues, Mechanism and Regulation of Class Switch Recombination by IgH transcriptional Control Elements, IL-2 partial agonist, Preserving Immune Homeostasis with A20, The design of vaccine strategies to elicit HIV-1 broadly neutralizing antibodies.
- Presents current developments and comprehensive reviews in immunology
- Provides the latest in a longstanding, respected serial on the subject matter
- Focuses on recent advances in the advancing area of the mechanisms involved in the evolution of HIV-1 neutralizing antibodies
| Contributors |
|
vii | |
|
1 Histone deacetylases as targets in autoimmune and autoinflammatory diseases |
|
|
1 | (60) |
|
|
|
|
|
|
|
|
|
2 | (1) |
|
2 Basic aspects of the biology of HDACs |
|
|
3 | (9) |
|
|
|
12 | (6) |
|
4 Inflammatory bowel diseases |
|
|
18 | (16) |
|
|
|
34 | (6) |
|
|
|
40 | (5) |
|
|
|
45 | (1) |
|
|
|
46 | (15) |
|
2 The role of NK cell as central communicators in cancer immunity |
|
|
61 | (28) |
|
|
|
|
|
|
|
|
|
|
|
62 | (2) |
|
2 NK cell cross-talk with innate immune cells |
|
|
64 | (9) |
|
3 Cross-talk of NK cells with adaptive immune cells |
|
|
73 | (2) |
|
4 Cross-talk of NK cell with stromal cells |
|
|
75 | (2) |
|
5 Impairment of NK cell communication |
|
|
77 | (3) |
|
|
|
80 | (1) |
|
|
|
80 | (1) |
|
|
|
81 | (1) |
|
|
|
81 | (8) |
|
3 Mechanism and regulation of class switch recombination by IgH transcriptional control elements |
|
|
89 | |
|
|
|
|
|
|
|
|
|
1 Overview of class switch recombination |
|
|
90 | (4) |
|
2 Role of IgH transcriptional control elements |
|
|
94 | (12) |
|
3 Class switch recombination in the CH12F3 cell line |
|
|
106 | (2) |
|
4 Class switch recombination in developing B cells |
|
|
108 | (2) |
|
5 Mechanism and regulation of class switch recombination |
|
|
110 | (14) |
|
|
|
124 | (2) |
|
|
|
126 | (1) |
|
|
|
127 | (1) |
|
Compliance with ethics guidelines |
|
|
127 | (1) |
|
|
|
127 | |
Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School.
